| Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan (NCT01018745) | Bristol-Myers Squibb | 2010-01-01 |
| Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (NCT01009593) | Abbott | 2010-01-01 |
| Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors (NCT00940498) | Pfizer | 2010-01-01 |
| A Study of MORAb-003 in Patients With Solid Tumor (NCT01049061) | Eisai Co., Ltd. | 2010-01-01 |
| The Diagnostic Value of Combinatory EUS and ERCP in Unclear Lesions (NCT03504293) | Sahlgrenska University Hospital | 2010-01-01 |
| Study of IMC-11F8 in Participants With Advanced Solid Tumors (NCT01088464) | Eli Lilly and Company | 2010-01-01 |
| Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) (NCT01026415) | Seagen Inc. | 2009-12-01 |
| Combination of BI6727 (Volasertib) and BIBF1120 in Solid Tumors (NCT01022853) | Boehringer Ingelheim | 2009-12-01 |
| Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer (NCT01023958) | Boehringer Ingelheim | 2009-11-19 |
| BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer (NCT00962611) | Bayer | 2009-11-19 |
| A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) (NCT00960063) | Merck Sharp & Dohme LLC | 2009-11-11 |
| A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors (NCT00985374) | Hoffmann-La Roche | 2009-11-01 |
| To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors (NCT01028755) | Bayer | 2009-11-01 |
| Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas (NCT01259518) | Trin Therapeutics GmbH | 2009-11-01 |
| Open Label Extension In Cancer Patients (NCT00830180) | Pfizer | 2009-10-29 |
| Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks (NCT01037049) | Royal Marsden NHS Foundation Trust | 2009-10-16 |
| Methylnaltrexone for Opioid-induced Constipation in Cancer Patients (NCT01004393) | University of Vermont | 2009-10-01 |
| Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. (NCT01003158) | AstraZeneca | 2009-10-01 |
| Phase I Dose Escalation Study of Concomitant BIBF 1120 and BIBW 2992 in Patients With Advanced Solid Tumours. (NCT00998296) | Boehringer Ingelheim | 2009-10-01 |
| Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) (NCT00954512) | Merck Sharp & Dohme LLC | 2009-09-25 |
| Computer Based Assessment and Treatment (NCT01795157) | Norwegian University of Science and Technology | 2009-09-01 |
| Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland (NCT00980213) | Pirkko-Liisa Kellokumpu-Lehtinen | 2009-09-01 |
| Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan (NCT00898716) | Bristol-Myers Squibb | 2009-09-01 |
| Enhanced Self-Efficacy Training (NCT00938769) | Duke University | 2009-08-01 |
| BI 6727 (Volasertib) in Combination With Cisplatin or Carboplatin in Patients With Advanced or Metastatic Solid Tumour (NCT00969761) | Boehringer Ingelheim | 2009-08-01 |
| Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers (NCT00969553) | Boehringer Ingelheim | 2009-08-01 |
| START: Swiss Taxotere Alopecia Prevention Trial (NCT01008774) | Sanofi | 2009-07-01 |
| The Use of FNA and FNB in the Optimization of EUS-assisted Tissue Sampling (NCT02360839) | Per Hedenström | 2009-07-01 |
| Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors (NCT00962494) | Stanford University | 2009-07-01 |
| Registry Study for Radiation Therapy Outcomes (NCT01255748) | Proton Collaborative Group | 2009-06-01 |
| Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II) (NCT00900627) | AstraZeneca | 2009-06-01 |
| Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2 (NCT00906698) | Boehringer Ingelheim | 2009-06-01 |
| p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage (NCT00894153) | Shenzhen SiBiono GeneTech Co.,Ltd | 2009-05-01 |
| Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors (NCT00838539) | Puma Biotechnology, Inc. | 2009-04-01 |
| Self-Management of Cancer-Related Fatigue by Adolescents (NCT00862186) | Seattle Children's Hospital | 2009-04-01 |
| Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours (NCT00875433) | Boehringer Ingelheim | 2009-03-01 |
| Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies (NCT00859118) | University of Wisconsin, Madison | 2009-02-01 |
| A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere® (NCT00877136) | St. Joseph Hospital of Orange | 2009-02-01 |
| A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors (NCT00811993) | Hoffmann-La Roche | 2009-02-01 |
| CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers (NCT00822809) | Neovii Biotech | 2008-12-01 |
| Phase I Study of BI 831266 in Patients With Advanced Solid Tumours (NCT00756223) | Boehringer Ingelheim | 2008-11-01 |
| A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors. (NCT00773526) | Hoffmann-La Roche | 2008-11-01 |
| A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors (NCT00783328) | Pfizer | 2008-11-01 |
| A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248) (NCT00779584) | Merck Sharp & Dohme LLC | 2008-10-17 |
| Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function (NCT00674024) | National Cancer Institute (NCI) | 2008-10-07 |
| Immunobiology of Cancer (NCT00767533) | Stanford University | 2008-10-01 |
| Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification. (NCT00748709) | Boehringer Ingelheim | 2008-10-01 |
| Hospital-based Home Care for Children With Cancer (NCT01538706) | Rigshospitalet, Denmark | 2008-08-01 |
| A Study of PF-04217903 in Patients With Advanced Cancer (NCT00706355) | Pfizer | 2008-08-01 |
| AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor (NCT00719524) | Sanofi | 2008-07-01 |
| A Study In Patients With Advanced Solid Tumor (NCT00726752) | Pfizer | 2008-07-01 |
| Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumours (NCT00716417) | Boehringer Ingelheim | 2008-07-01 |
| A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004) (NCT00730379) | Merck Sharp & Dohme LLC | 2008-07-01 |
| A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors. (NCT00721266) | Hoffmann-La Roche | 2008-06-01 |
| AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers (NCT00678132) | National Cancer Institute (NCI) | 2008-04-24 |
| Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-2206-002) (NCT00670488) | Merck Sharp & Dohme LLC | 2008-04-15 |
| Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia (NCT00735813) | Aarhus University Hospital | 2008-04-01 |
| Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors (NCT00569036) | Bristol-Myers Squibb | 2008-04-01 |
| A Shared Care Approach for Seriously Ill Cancer Patients Between General Practice, Discharge Department and a Specialist Palliative Care Team (NCT00594971) | University of Aarhus | 2008-04-01 |
| SNX-5422 to Treat Solid Tumor Cancers and Lymphomas (NCT00644072) | National Cancer Institute (NCI) | 2008-03-07 |
| End-of-Life Health Care Decisions by Patients With Advanced Cancer (NCT02265601) | Milton S. Hershey Medical Center | 2008-03-01 |
| A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors. (NCT00651365) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-02-01 |
| A Study to Evaluate the Effect of Far Infrared Radiation for Cancer Treatment (NCT00574106) | GAAD Medical Research Institute Inc. | 2008-02-01 |
| Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue (NCT01043913) | Faculdade de Medicina do ABC | 2008-02-01 |
| Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors (NCT00879684) | Pfizer | 2008-01-01 |
| Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry (NCT04996732) | Fudan University | 2008-01-01 |
| Sorafenib Long Term Extension Program (NCT00625378) | Bayer | 2007-12-21 |
| A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors (NCT00559533) | Hoffmann-La Roche | 2007-12-01 |
| A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours (NCT00566410) | AHS Cancer Control Alberta | 2007-12-01 |
| A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors. (NCT00560144) | Hoffmann-La Roche | 2007-12-01 |
| A Study Of PF-03732010 In Patients With Advanced Solid Tumors (NCT00557505) | Pfizer | 2007-12-01 |
| Malignancies in Transplanted Patients (NCT02241564) | Uppsala University | 2007-11-01 |
| Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors (NCT00607048) | Hoffmann-La Roche | 2007-11-01 |
| A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors. (NCT00532090) | Hoffmann-La Roche | 2007-11-01 |
| Sorafenib/Docetaxel Dose Escalation Trial (NCT00562523) | Bayer | 2007-11-01 |
| Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer (NCT00547261) | Sanofi | 2007-10-01 |
| A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients (NCT00545246) | Sanofi | 2007-10-01 |
| A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors (NCT00503451) | Novartis Pharmaceuticals | 2007-09-01 |
| Low Rectal Cancer Study (MERCURY II) (NCT02005965) | Royal Marsden NHS Foundation Trust | 2007-08-13 |
| Methadone Versus Morphine for Cancer-Related Pain (NCT00573937) | Mayo Clinic | 2007-08-01 |
| Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy (NCT00725387) | Stanford University | 2007-08-01 |
| A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. (NCT00677105) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-08-01 |
| Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer (NCT00490334) | Stanford University | 2007-08-01 |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. (NCT00448136) | Hoffmann-La Roche | 2007-07-01 |
| A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment (NCT01561911) | Cancer Research UK | 2007-07-01 |
| Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer (NCT00487786) | Achieve Life Sciences | 2007-06-01 |
| Acupuncture in Palliative Cancer Care (NCT00302185) | British Columbia Cancer Agency | 2007-06-01 |
| BI 811283 in Various Solid Tumours (NCT00701324) | Boehringer Ingelheim | 2007-06-01 |
| Barrett's Esophagus Related Neoplasia (BERN) Project (NCT00590239) | Midwest Biomedical Research | 2007-05-15 |
| Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours (NCT00809133) | Boehringer Ingelheim | 2007-05-01 |
| Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors (NCT00606125) | Bayer | 2007-05-01 |
| Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines (NCT00838370) | The Netherlands Cancer Institute | 2007-05-01 |
| Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours (NCT00475956) | AstraZeneca | 2007-05-01 |
| Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma (NCT01445340) | National Cancer Institute (NCI) | 2007-04-21 |
| Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED) (NCT00684463) | Merck Sharp & Dohme LLC | 2007-04-11 |
| A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan (NCT00421811) | Adherex Technologies, Inc. | 2007-04-01 |
| A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued. (NCT00378482) | AstraZeneca | 2007-03-05 |
| A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients (NCT00479076) | Sanofi | 2007-03-01 |
| Phase I Study in Patients With Solid Tumours (NCT00496028) | AstraZeneca | 2007-03-01 |
| A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors (NCT00879554) | Pfizer | 2007-02-01 |